Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
H. Mcshane (Oxford (Oxfordshire), United Kingdom). Latest insights and challenges in tuberculosis vaccine development. International Congress 2019 – Tuberculosis: latest advances and challenges in patient management

Member's Comments

No comment yet.

Related content which might interest you: Influenza surveillance and vaccination: new developments Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice Year: 2017 Future prospects for improved influenza vaccines Source: Annual Congress 2007 - Respiratory issues in primary care Year: 2007 COVID-19 vaccines: immunology, regulation and clinical management Source: Eur Respir Monogr 2021; 94: 244-260 Year: 2021 Facts and perspectives in the development of new diagnostics Source: Annual Congress 2008 - New insights into tuberculosis control Year: 2008 Moving tuberculosis vaccines from theory to practice Source: International Congress 2019 – Vaccines against respiratory infections Year: 2019 Translating scientific discoveries during pandemics: ensuring equity for people affected by COVID-19 and tuberculosis Source: ERJ Open Res, 6 (4) 00562-2020; 10.1183/23120541.00562-2020 Year: 2020 Towards a new vaccine for tuberculosis Source: Eur Respir Monogr 2018; 82: 343-363 Year: 2018 COPD – will new insights into molecular pathology define new therapies? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations Source: Eur Respir J, 55 (3) 1901957; 10.1183/13993003.01957-2019 Year: 2020 Chronic cough: new insights and future prospects Source: Eur Respir Rev, 30 (162) 210127; 10.1183/16000617.0127-2021 Year: 2021 Assessing the worldwide epidemiology of sarcoidosis: challenges and future directions Source: Eur Respir J 2016; 48: 1545-1548 Year: 2016 Outlook: Future developments for the diagnosis of MTB infection Source: Annual Congress 2008 - PG20 - Advances in the diagnosis of Mycobacterium tuberculosis infection: an interactive, case-based course Year: 2008 State of the art in vaccine development against TB Source: Eur Respir Mon 2012; 58: 59-71 Year: 2012 Clinical implications and opportunities for new drug therapies Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications Year: 2008 Dynamics of IFN-ß responses during respiratory viral infection: insights for therapeutic strategies Source: International Congress 2019 – Mechanisms underlying respiratory infection Year: 2019